Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Tuomainen, Tomi Pekka ^a   Virtanen, Jyrki K ^a   Voutilainen, Sari ^a   Nurmi, Tarja ^a   Mursu, Jaakko ^a   De Mello, Vanessa D F ^a   Schwab, Ursula ^a,b   Hakumäki, Martti ^a   Pulkki, Kari ^a   Uusitupa, Matti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIFEDIOL; COLECALCIFEROL; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR RECEPTOR 2; CYTOKINE; GLUCOSE BLOOD LEVEL; IL1B PROTEIN, HUMAN; IL1RN PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; VITAMIN;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FINLAND; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INTERVENTION STUDY; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREND STUDY; VITAMIN SUPPLEMENTATION; BLOOD; COMPLICATION; DIETARY SUPPLEMENT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PREDIABETIC STATE; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CALCIFEDIOL; CHOLECALCIFEROL; CYTOKINES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; OVERWEIGHT; PREDIABETIC STATE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TREATMENT OUTCOME; VITAMINS;

EID: 84935840801     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/672653     Document Type: Article

References (31)

1. H. Khan, S. Kunutsor, O. H. Franco, and R. Chowdhury, "Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies, " Proceedings of theNutrition Society, vol. 72, no. 1, pp. 89-97, 2013.
2. N. G. Forouhi, Z. Ye, A. P. Rickard, et al., "Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of Prospective studies, " Diabetologia, vol. 55, no. 8, pp. 2173-2182, 2012.
3. P. S. George, E. R. Pearson, and M. D. Witham, "Effectof vitamin Dsupplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis, " Diabetic Medicine, vol. 29, no. 8, pp. e142-e150, 2012.
4. S. Nazarian, J. V. St. Peter, R. C. Boston, S. A. Jones, and C. N. Mariash, "Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose, " Translational Research, vol. 158, no. 5, pp. 276-281, 2011.
5. J. Mitri, B. Dawson-Hughes, F. B. Hu, and A. G. Pittas, "Effects of vitamin D and calcium supplementation on pancreatic γ cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) rand omized controlled trial, " The American Journal of Clinical Nutrition, vol. 94, no. 2, pp. 486-494, 2011.
6. D. Dutta, S. A. Mondal, S. Choudhuri, et al., "Vitamin-D supplementation in prediabetes reduced progression to type diabetes and was associated with decreased insulin resistance and systemic inflammation: An open label rand omized prospective study from Eastern India, " Diabetes Research and Clinical Practice, vol. 103, no. 3, pp. e18-e23, 2014.
7. C. Gagnon, R. M. Daly, A. Carpentier, et al., "Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and beta-cell function in multiethnic vitamin D-deficient adults at risk for Type 2 diabetes: a Pilot Rand omized, Placebo-Controlled Trial, " PLoS ONE, vol. 9, no. 10, Article ID e109607, 2014.
8. S. S. Harris, A. G. Pittas, and N. J. Palermo, "A rand omized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans, " Diabetes, Obesity and Metabolism, vol. 14, no. 9, pp. 789-794, 2012.
9. M. B. Davidson, P. Duran, M. L. Lee, and T. C. Friedman, "Highdose vitaminDsupplementation in people with prediabetes and hypovitaminosis D, " Diabetes Care, vol. 36, no. 2, pp. 260-266, 2013.
10. J. Beilfuss, V. Berg, M. Sneve, R. Jorde, and E. Kamycheva, "Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects, " Cytokine, vol. 60, no. 3, pp. 870-874, 2012.
11. B. Feve and J.-P. Bastard, "The role of interleukins in insulin resistance and type 2 diabetes mellitus, " Nature Reviews Endocrinology, vol. 5, no. 6, pp. 305-311, 2009.
12. C. M. Elks and J. Francis, "Central adiposity, systemic inflammation, and the metabolic syndrome, " Current Hypertension Reports, vol. 12, no. 2, pp. 99-104, 2010.
13. C. E. A. Chagas, M. C. Borges, L. A. Martini, and M. M. Rogero, "Focus on vitamin D, inflammation and type 2 diabetes, " Nutrients, vol. 4, no. 1, pp. 52-67, 2012.
14. T. Nurmi, T.-P. Tuomainen, J. Virtanen, J. Mursu, and S. Voutilainen, "High-performance liquid chromatography and coulometric electrode array detector in serum25-hydroxyvitaminD3 and 25-hydroxyvitamin D2 analyses, " Analytical Biochemistry, vol. 435, no. 1, pp. 1-9, 2013.
15. T. M. Wallace, J. C. Levy, and D. R. Matthews, "Use and abuse of HOMA modeling, " Diabetes Care, vol. 27, no. 6, pp. 1487-1495, 2004.
16. D. I. Phillips, P. M. Clark, C. N. Hales, and C. Osmond, "Understand ing oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion, " Diabetic Medicine, vol. 11, no. 3, pp. 286-292, 1994.
17. M. Matsuda and R. A. DeFronzo, "Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp, " Diabetes Care, vol. 22, no. 9, pp. 1462-1470, 1999.
18. J. K. Virtanen, T. Nurmi, S. Voutilainen, J. Mursu, and T.-P. Tuomainen, "Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland, " European Journal of Nutrition, vol. 50, no. 5, pp. 305-312, 2011.
19. A. G. Pittas, S. S. Harris, P. C. Stark, and B. Dawson-Hughes, "The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults, " Diabetes Care, vol. 30, no. 4, pp. 980-986, 2007.
20. A.-R. Hurskainen, J. K. Virtanen, T.-P. Tuomainen, T. Nurmi, and S. Voutilainen, "Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland, " Diabetes/Metabolism Research and Reviews, vol. 28, no. 5, pp. 418-423, 2012.
21. Z. Ye, S. J. Sharp, S. Burgess, et al., "Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian rand omisation study, " The Lancet Diabetes & Endocrinology, vol. 3, no. 1, pp. 35-42, 2015.
22. U. Salmenniemi, E. Ruotsalainen, J. Pihlajamaki, et al., "Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome, " Circulation, vol. 110, no. 25, pp. 3842-3848, 2004.
23. C. Herder, E. J. Brunner, W. Rathmann, et al., "Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: thewhitehall II study, " Diabetes Care, vol. 32, no. 3, pp. 421-423, 2009.
24. M. Carstensen, C. Herder, M. Kivimaki, et al., "Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: whitehall II prospective cohort study, " Diabetes, vol. 59, no. 5, pp. 1222-1227, 2010.
25. A. Zittermann, S. Frisch, H. K. Berthold, et al., "Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers, " The American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1321-1327, 2009.
26. P. J. Matias, C. Jorge, C. Ferreira, et al., "Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters, " Clinical Journal of the American Society of Nephrology, vol. 5, no. 5, pp. 905-911, 2010.
27. S. Bucharles, S. H. Barberato, A. E. M. Stinghen, et al., "Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism, " Journal of Renal Nutrition, vol. 22, no. 2, pp. 284-291, 2012.
28. M. P. Bjorkman, A. J. Sorva, and R. S. Tilvis, "C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial, " Journal of Nutrition, Health and Aging, vol. 13, no. 5, pp. 435-439, 2009.
29. P. R. von Hurst, W. Stonehouse, and J. Coad, "Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a rand omised, placebo-controlled trial, " British Journal of Nutrition, vol. 103, no. 4, pp. 549-555, 2010.
30. R. Jorde, M. Sneve, P. A. Torjesen, Y. Figenschau, L. G. Gøransson, and R. Omdal, "No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects, " Cytokine, vol. 50, no. 2, pp. 175-180, 2010.
31. J. A. Alvarez, S. M. Zughaier, J. Law, et al., "Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease, " European Journal of Clinical Nutrition, vol. 67, no. 3, pp. 264-269, 2013.